추천 제품
product name
F-36P, 99072808
생물학적 소스
human bone
성장 모드
Suspension
핵형
43,Y(Xp+,-5,-7,-13,-16,-17,-19,-21,2q-,9p+,10q+,+4mar)
형태학
Lymphoblastoid
제품
Not specified
수용체
Not specified
기술
cell culture | mammalian: suitable
관련 질환(들)
cancer
배송 상태
dry ice
저장 온도
−196°C
세포주 기원
Human leukemia, myelodysplastic syndrome
세포주 설명
The cell line F-36P has been established from a 65 year old male patient, who was diagnosed with refractory anaemia with excess blasts (RAEB), a subtype of myelodysplastic syndrome (MDS). This non-lymphoid leukemia line was obtained from the patient′s pleural fluid at time of progressed to overt leukemia. F-36P is cytokine-dependent requiring granulocyte-macrophage colony-stimulating factor (GM-CSF) or Interleukin 3 (IL-3). Cells have been shown to synthesize haemoglobin when GM-CSF or IL-3 is substituted by erythropoietin (Epo). They have been reported to be positive for leukocyte common antigen (CD45) and some multilineage markers such as CD13, CD33 and CD34, but are negative for T- and B-cell antigens and mature myelomonocytic antigens. Due to their reaction with some monoclonal antibodies recognising erythroid and platelet glycoproteins it has been suggested that F-36P has a multilineage phenotype.
애플리케이션
Study of differentiation and effect of growth signals
DNA 프로파일
STR-PCR Data: Amelogenin: X,Y
CSF1PO: 9
D13S317: 10
D16S539: 10,12
D5S818: 13
D7S820: 9,11
THO1: 8
TPOX: 9,11
vWA: 14,16
CSF1PO: 9
D13S317: 10
D16S539: 10,12
D5S818: 13
D7S820: 9,11
THO1: 8
TPOX: 9,11
vWA: 14,16
배양 배지
RPMI 1640 + 2mM Glutamine + 5ng/ml rh IL-3 + 5% Foetal Bovine Serum (FBS).
계대배양 정규 작업
Maintain cultures between 3-9 x 100,000 cells/ml; 5%CO2; 37ºC.
기타 정보
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.